HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Generate Investment Management Ltd

Generate Investment Management Ltd lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 72.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,164 shares of the company's stock after selling 66,580 shares during the period. Generate Investment Management Ltd's holdings in HCA Healthcare were worth $8,695,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Congress Wealth Management LLC DE increased its position in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after purchasing an additional 34 shares in the last quarter. Evergreen Private Wealth LLC increased its position in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after acquiring an additional 35 shares during the period. Whittier Trust Co. increased its position in HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after acquiring an additional 41 shares during the period. Barden Capital Management Inc. increased its position in HCA Healthcare by 1.4% in the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after acquiring an additional 41 shares during the period. Finally, Coldstream Capital Management Inc. increased its position in HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock valued at $1,042,000 after acquiring an additional 44 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on HCA shares. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Guggenheim began coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Royal Bank Of Canada lifted their price objective on HCA Healthcare from $376.00 to $404.00 and gave the company an "outperform" rating in a report on Monday. Seven research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and an average price target of $394.33.

HCA Healthcare Trading Up 0.1%

Shares of HCA Healthcare stock opened at $379.06 on Wednesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market capitalization of $91.19 billion, a P/E ratio of 16.85, a P/E/G ratio of 1.31 and a beta of 1.49. The business has a 50 day moving average price of $363.94 and a 200 day moving average price of $335.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same period in the previous year, the firm posted $5.36 EPS. The company's quarterly revenue was up 5.7% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.